• Products
  • Statistics and Data Mining Solutions
  • Statistics and Data Mining Services
  • Statistics and Data Mining Resources
  • Support
  • News and Events
  • Company
S+SeqTrial is the perfect tool for designing and monitoring clinical trials including a comprehensive selection of validated designs integrated with powerful data analysis capabilities. Its easy-to-use graphical user interface and professional graphics are ideal for communicating results to non-statisticians and FDA reporting. S+SeqTrial will help our company to make decisions to terminate or continue trials sooner, potentially saving lives and reducing clinical trial costs.
Gracie Liebermann
Biostatistician
Genentech
Home / Products / S+SeqTrial

S+SeqTrial

THE PREMIER PACKAGE FOR THE DESIGN, MONITORING, AND ANALYSIS OF CLINICAL TRIALS

S+SeqTrial is an S-PLUS software library for designing, monitoring, and analyzing clinical trials using group sequential methods. In a classical fixed sample design, the sample size is set in advance of collecting any data. In sequential design, data are monitored throughout the collection, and the data may be analyzed after a block of data is accrued. This is especially beneficial if electronic data capture (EDC) methods are used for data collection.

S+SeqTrial Image
Group sequential designs are especially important for the design of Phase II and Phase III clinical trials, where ethical considerations such as patient safety and rapid approval of effective treatments are paramount. Indeed, the FDA now recommends group sequential studies in certain cases.

Key Benefits

  • Reduced clinical trial costs using group sequential methods
  • Improved study design and comprehensive design and evaluation tools
  • Flexible monitoring methods
  • Advanced visualization tools for analyzing and interpreting results
RELATED LINKS